| The 2016 World Health Organization classification of tumors of the central nervous system: a summary DN Louis, A Perry, G Reifenberger, A Von Deimling, D Figarella-Branger, ... Acta neuropathologica 131, 803-820, 2016 | 17218 | 2016 |
| The 2021 WHO classification of tumors of the central nervous system: a summary DN Louis, A Perry, P Wesseling, DJ Brat, IA Cree, D Figarella-Branger, ... Neuro-oncology 23 (8), 1231-1251, 2021 | 8295 | 2021 |
| New brain tumor entities emerge from molecular classification of CNS-PNETs D Sturm, BA Orr, UH Toprak, V Hovestadt, DTW Jones, D Capper, M Sill, ... Cell 164 (5), 1060-1072, 2016 | 898 | 2016 |
| I nternational S ociety of N europathology‐H aarlem C onsensus G uidelines for N ervous S ystem T umor C lassification and G rading DN Louis, A Perry, P Burger, DW Ellison, G Reifenberger, A von Deimling, ... Brain pathology 24 (5), 429-435, 2014 | 694 | 2014 |
| OPA1 mutations induce mitochondrial DNA instability and optic atrophy ‘plus’ phenotypes P Amati-Bonneau, ML Valentino, P Reynier, ME Gallardo, B Bornstein, ... Brain 131 (2), 338-351, 2008 | 583 | 2008 |
| cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading DN Louis, P Wesseling, K Aldape, DJ Brat, D Capper, IA Cree, C Eberhart, ... Brain Pathology 30 (4), 844-856, 2020 | 549 | 2020 |
| A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up J Trouillas, P Roy, N Sturm, E Dantony, C Cortet-Rudelli, G Viennet, ... Acta neuropathologica 126, 123-135, 2013 | 518 | 2013 |
| cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant DN Louis, C Giannini, D Capper, W Paulus, D Figarella-Branger, ... Acta neuropathologica 135, 639-642, 2018 | 411 | 2018 |
| Central neurocytoma: a synopsis of clinical and histological features J Hassoun, F Söylemezoglu, D Gambarelli, D Figarella‐Branger, ... Brain Pathology 3 (3), 297-306, 1993 | 409 | 1993 |
| Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial B Lannering, S Rutkowski, F Doz, B Pizer, G Gustafsson, A Navajas, ... Journal of clinical oncology 30 (26), 3187-3193, 2012 | 388 | 2012 |
| Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis S Rutkowski, K Von Hoff, A Emser, I Zwiener, T Pietsch, ... Journal of clinical oncology 28 (33), 4961-4968, 2010 | 371 | 2010 |
| SCENITH: a flow cytometry-based method to functionally profile energy metabolism with single-cell resolution RJ Argüello, AJ Combes, R Char, JP Gigan, AI Baaziz, E Bousiquot, ... Cell metabolism 32 (6), 1063-1075. e7, 2020 | 348 | 2020 |
| Pilocytic astrocytomas in children: prognostic factors—a retrospective study of 80 cases C Fernandez, D Figarella-Branger, N Girard, C Bouvier-Labit, J Gouvernet, ... Neurosurgery 53 (3), 544-555, 2003 | 337 | 2003 |
| Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis P Metellus, B Coulibaly, C Colin, AM de Paula, A Vasiljevic, D Taieb, ... Acta neuropathologica 120, 719-729, 2010 | 328 | 2010 |
| Macrophagic myofasciitis: an emerging entity RK Gherardi, M Coquet, P Chérin, FJ Authier, P Laforêt, L Belec, ... The Lancet 352 (9125), 347-352, 1998 | 321 | 1998 |
| Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts DW Ellison, M Kocak, D Figarella-Branger, G Felice, G Catherine, ... Journal of negative results in biomedicine 10, 1-13, 2011 | 320 | 2011 |
| Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes K Nguyen, G Bassez, M Krahn, R Bernard, P Laforêt, V Labelle, ... Archives of neurology 64 (8), 1176-1182, 2007 | 305 | 2007 |
| Stereoelectroencephalography in presurgical assessment of MRI-negative epilepsy A McGonigal, F Bartolomei, J Régis, M Guye, M Gavaret, ATD Fonseca, ... Brain 130 (12), 3169-3183, 2007 | 288 | 2007 |
| CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas R Appay, C Dehais, CA Maurage, A Alentorn, C Carpentier, C Colin, ... Neuro-oncology 21 (12), 1519-1528, 2019 | 286 | 2019 |
| Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas A Gonzalez-Aguilar, A Idbaih, B Boisselier, N Habbita, M Rossetto, ... Clinical cancer research 18 (19), 5203-5211, 2012 | 278 | 2012 |
